GRITTI, GIUSEPPE
GRITTI, GIUSEPPE
Universita' degli Studi di MILANO
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies
2021 F. Lussana, G. Gritti, A. Rambaldi
Italian real life experience with brentuximab vedotin : results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma
2017 C. Pellegrini, A. Broccoli, A. Pulsoni, L. Rigacci, C. Patti, G. Gini, D. Mannina, M. Tani, C. Rusconi, A. Romano, A. Vanazzi, B. Botto, A. Santoro, S. Hoaus, G.M. Rigolin, P. Musto, P. Mazza, S. Molica, P. Corradini, A. Fama, F. Gaudio, M. Merli, F. Ronconi, G. Gritti, D. Vallisa, P. Tosi, A.M. Liberati, A. Pinto, V. Pavone, F. Gherlinzoni, M.P. Bianchi, S. Volpetti, L. Trentin, M.C. Goldaniga, M. Bonfichi, A. De Renzo, C. Schiavotto, M. Spina, A.M. Carella, V. Stefoni, L. Argnani, P.L. Zinzani
Italian real life experience with brentuximab vedotin : results of a large observational study on 40 relapsed/refractory systemic anaplastic large cell lymphoma
2017 A. Broccoli, C. Pellegrini, A. Di Rocco, B. Puccini, C. Patti, G. Gini, D. Mannina, M. Tani, C..M. Rusconi, A. Romano, A. Vanazzi, B. Botto, C. Carlo Stella, S. Hohaus, P. Musto, P. Mazza, S. Molica, P. Corradini, A. Fama, F. Gaudio, M. Merli, A. Gravetti, G. Gritti, A. Arcari, P. Tosi, A.M. Liberati, A. Pinto, V. Pavone, F. Gherlinzoni, V. Naso, S. Volpetti, L. Trentin, M.C. Goldaniga, M. Bonfichi, A. De Renzo, C. Schiavotto, M. Spina, S. Storti, A.M. Carella, V. Stefoni, L. Argnani, P.L. Zinzani
Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas
2015 G. Gritti, C. Boschini, A. Rossi, F. Delaini, A. Grassi, A. Algarotti, C. Micò, R. Trezzi, A. Gianatti, A.M. Barbui, A. Rambaldi
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia : a GIMEMA multicenter phase II trial
2014 A. Cortelezzi, M. Sciumè, A.M. Liberati, D. Vincenti, A. Cuneo, G. Reda, L. Laurenti, F. Zaja, R. Marasca, A. Chiarenza, G. Gritti, L. Orsucci, S. Storti, E. Angelucci, N. Cascavilla, M. Gobbi, F.R. Mauro, F. Morabito, S. Fabris, A. Piciocchi, M. Vignetti, A. Neri, D. Rossi, D. Giannarelli, A. Guarini, R. Foà
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy
2013 A. Rambaldi, C. Boschini, G. Gritti, F. Delaini, E. Oldani, A. Rossi, A.M. Barbui, D. Caracciolo, M. Ladetto, A. Gueli, A. De Crescenzo, R. Passera, L. Devizzi, C. Patti, A.M. Gianni, C. Tarella
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
2012 G. Gritti, G. Reda, F. Maura, A. Piciocchi, L. Baldini, S. Molica, A. Neri, A. Cortelezzi
Stereotyped B-cell receptor is associated with immune thrombocytopenia in CLL
2011 F. Maura, C. Visco, E. Novella, I. Giaretta, G. Tuana, L. Agnelli, M. Lionetti, S. Fabris, F. Guidotti, G. Reda, G. Gritti, W. Barcellini, A. Neri, A. Cortelezzi, F. Rodeghiero
IGHV gene analysis in chronic lymphocytic leukemia
2010 F. Maura, G. Gritti, G. Reda, K. Aprile Von Hohenstaufen Puoti, V. Ferla, M. Sciumè, L. Cro, M. Pomati, S. Fabris, M. Lionetti, L. Baldini, A. Neri, G. Lambertenghi Deliliers, A. Cortelezzi
Ineffective hematopoiesis and markers of angiogeneisis in myelodysplastic syndromes
2009 A. Cortelezzi, G. Gritti, S. Lonati, I. Silvestris, N. Orofino, K.I.Y. APRILE VON HOHENSTAUFEN PUOTI, G. Reda, A. Freyrie, G. Lambertenghi Deliliers
Circulating versus progenitor endothelial cells are abnormal in patients with different types of Von Willebrand disease and correlate with markers of angiogenesis : a cohort study of 74 cases
2009 G. Gritti, A.B. Federici, A. Cortelezzi, P. Bucciarelli, M. Punzo, S. Lonati, F. Rezzonico, I. Silvestris, V. Rubini, S. La Marca, G. Lambertenghi Deliliers, P.M. Mannucci
Markers of angiogenesis in von willbrand disease
2008 G. Gritti, A. Cortelezzi, S. Lonati, I. Silvestris, G. Lambertenghi Deliliers, M. Punzo, R. Garavaglia, L. Baronciani, M.T. Canciani, A.B. Federici
Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status
2008 A. Cortelezzi, G. Gritti, N. Del Papa, M.C. Pasquini, R. Calori, U. Gianelli, M. Cortiana, G. Parati, F. Onida, F. Sozzi, C. Vener, P. Bianchi, G. Lambertenghi Deliliers
Circulating Versus Progenitor Endothelial Cells Levels Are Abnormal in Patients with Different Types of Von Willebrand Disease and Correlate with Markers of Angiogenesis
2008 G. Gritti, A.B. Federici, A. Cortelezzi, L. Baronciani, S. Lonati, M. Punzo, I. Silvestris, R. Garavaglia, G. Lambertenghi Deliliers, P.M. Mannucci
Evalutation of TIE2-expressing monocytes in myeloid disorders
2008 A. Cortelezzi, G. Gritti, S. Lonati, I. Silvestris, A. Freyrie, G. Reda, G. Lambertenghi Deliliers
Chronic idiopathic myelofibrosis complicated by pulmonary arterial hypertension is distinctively characterized by endothelial progenitor cell insufficiency and increased angiogenesis
2007 A. Cortelezzi, G. Gritti, N. Del Papa, M.C. Pasquini, M. Cortiana, I. Silvestris, R. Calori, U. Gianelli, C. Vener, F. Sozzi, G. Parati, G. Lambertenghi Deliliers